EDITOR—Gottlieb reports the criticism of the editorial in JAMA mentioning celecoxib, an arthritis drug, 1 2 but surely more censure should be reserved for the journal that published the article and its reviewers. It …
No takes yet. Share an insight, caveat, or question.
C J Hawkey (2001) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: